GAM
GCVRZ

Gemmer Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Gemmer Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-54
Closed – – 1549
2014
Q1 		$0 Buy
+54
New +$20 ﹤0.01% 1454

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Gemmer Asset Management's GCVRZ Position: Q2 2014 in Review

Gemmer Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2014, closing a stake of 54 shares.

Gemmer Asset Management first reported a position in GCVRZ in Q1 2014 and held it in 1 quarter. The position peaked at $0 in Q1 2014. 124 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2014.

  • Gemmer Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q2 2014 after selling out during the quarter.
  • Gemmer Asset Management sold 54 Sanofi Contingent Value Rights shares in Q2 2014.
  • Gemmer Asset Management first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 1 quarter.
  • Gemmer Asset Management's Sanofi Contingent Value Rights position peaked at $0 in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2014.

Based on Gemmer Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.